Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.

Oncoimmunology · 2016 · PMC5215252 · PMID 28123875

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Single BRAFi or MEKi in combination with PD-1 blockade also reduced tumor outgrowth as compared to single BRAFi or MEKi alone, but did not reach statistical significance ( Fig. 2B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.